PETS PetMed Express Inc.

PetMed Express, Inc. Sets Fiscal Second Quarter 2024 Earnings Call

PetMed Express, Inc. Sets Fiscal Second Quarter 2024 Earnings Call

DELRAY BEACH, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: PETS) (the “Company”), Your Trusted Pet Health ExpertTM will hold a conference call on Monday, October 30, 2023 at 4:30pm Eastern time to discuss its financial results for the fiscal second quarter ended September 30, 2023. Financial results will be issued in a press release prior to the call.

PetMeds’ management will host the conference call, followed by a question and answer period.

Date: Monday, October 30, 2023

Time: 4:30pm Eastern time (1:30pm Pacific time)

U.S. dial-in number: 877-407-0791

International number: 201-689-8563

Webcast:

Please call the conference telephone number 5-10 minutes prior to the start time. If you have any difficulty connecting with the conference call, please contact MZ Group at 561-374-0177.

A telephonic replay of the conference call will also be available after 7:30 PM Eastern time on the same day through November 13, 2023.

Toll-free replay number: 844-512-2921

International replay number: 412-317-6671

Replay passcode: 13741999

About PetMed Express

Founded in 1996, PetMeds is Your Trusted Pet Health ExpertTM, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at .

Forward-Looking Statements

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2023. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

Investor Contact:

MZ North America

Brian M. Prenoveau, CFA



(561) 489-5315



EN
19/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetMed Express Inc.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 16, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

PetMed Express, Inc. Announces Management Changes

PetMed Express, Inc. Announces Management Changes DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D’Elia, have resigned from their positions and employment with the Company. As part of the leadership changes, Leslie C.G. Campbell, the Chair of the Company’s Board of Directors (the “Board”), has assumed the role of Interim Chief Executive Officer, and Douglas Krulik, the Company’s Chief Acc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch